You are here
- Home
- Therapy Areas
- Neuroscience
A 1-year, international, multicenter, randomized, double-blind, parallel-group, placebo-controlled phase IV study to evaluate prevention of relapse in patients in stable condition with chronic schizophrenia receiving either quetiapine fumarate IR (SEROQUEL) or placebo.
- Disease
- schizophrenia
- Drug Name
- Seroquel
- Generic Name
- quetiapine
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- IV
- Start Date
- Jan 18, 1971
- Study Name
- D1441C00131
- Study Id
- D1441C00131
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
